The standard per-dose stack is 6 units (100 mcg Ipamorelin + 100 mcg CJC-1295), 23x daily, injected subcutaneously on an empty stomach
EASD 2018: the struggles of GSKs GLP-1 receptor agonist , (October 3, 2018)
Reconstitution What you need Bacteriostatic water (BAC water) Insulin syringe (29-31 gauge, 0.5-1mL) Alcohol swabs Sterile vial of cagrilintide powder Sharps container for safe needle disposal Injection Route Subcutaneous injection once weekly Best sites Abdomen (2 inches away from navel) Front of thigh (middle third) Upper arm (outer area) Lower back area (above buttocks) Technique 1.Wash hands thoroughly and clean injection site with alcohol swab 2.Let the alcohol dry completely - this reduces stinging 3.Pinch the skin to create a fold for easier injection 4.Insert needle at a 45-90 degree angle depending on body composition 5.Inject the medication slowly over 5-10 seconds 6.Hold for 10 seconds before removing needle, then release skin Storage Signs of degradation Sample Daily Schedule Safety Is it safe

Similar content being viewed by others Introduction Glucagon-like peptide-1 (GLP-1), an incretin hormone secreted by intestinal enteroendocrine cells, is pivotal for postprandial glucose homeostasis through its modulation of insulin and glucagon secretion, appetite suppression, and gastric emptying [1]
FDA Approval Semaglutide : Approved for type 2 diabetes management (Ozempic) and chronic weight management (Wegovy)
Offers a GLP-1 journey option and personalized solutions for diabetes, hypertension, and metabolic syndrome, with strong B2B and employer-focused integrations